Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCC1 | P33527 | 20/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 10/20 | 0.66 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.58 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923424 | 0.88 | ABCC1 (0.81) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6922763 | 0.86 | ABCC1 (0.77) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6924095 | 0.84 | ABCC1 (0.79) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6923315 | 0.84 | ABCC1 (0.84) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6922901 | 0.83 | ABCC1 (0.82) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6925209 | 0.82 | ABCC1 (0.73) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6918220 | 0.81 | ABCC1 (0.86) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6826415 | 0.80 | ABCC1 (1.00) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6922256 | 0.80 | ABCC1 (0.77) | ABCC1CYP3A4ABCB1ABCG2 | |
| SCHEMBL6827154 | 0.80 | ABCC1 (1.00) | ABCC1CYP3A4ABCB1ABCG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004111052-A1 | PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) | XENOVA LIMITED (GB) | 2004-12-23 | — | — | WO | claimed |
| WO-2004111052-A1 | PYRROLOPYRIMIDINE DERIVATIVES AS MODULATORS OF MULTI-DRUG RESISTANCE (MDR) | XENOVA LIMITED (GB) | 2004-12-23 | — | — | WO | disclosed |